Sign In
Buy RGEN
$121.73
+0.600 (+0.495%)
At Close: Jun 03, 2026
Repligen (RGEN) Q3 Earnings and Revenues Top Estimates
09:47am, Tuesday, 01'st Nov 2022
Repligen (RGEN) delivered earnings and revenue surprises of 13.24% and 4.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report?
04:10pm, Monday, 31'st Oct 2022 Zacks Investment Research
Repligen (RGEN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report?
01:33pm, Monday, 31'st Oct 2022
Repligen (RGEN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Gritstone bio Inc. (GRTS) Expected to Beat Earnings Estimates: Should You Buy?
02:01pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
Gritstone bio Inc. (GRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LGND vs. RGEN: Which Stock Is the Better Value Option?
03:40pm, Friday, 21'st Oct 2022 Zacks Investment Research
LGND vs. RGEN: Which Stock Is the Better Value Option?
LGND vs. RGEN: Which Stock Is the Better Value Option?
12:48pm, Friday, 21'st Oct 2022
LGND vs. RGEN: Which Stock Is the Better Value Option?
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
05:52am, Thursday, 20'th Oct 2022 Benzinga
Gainers
Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of E
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
04:30pm, Wednesday, 19'th Oct 2022 Benzinga
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
Scopus BioPharma Inc. (NASDAQ:
Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday
02:36pm, Wednesday, 19'th Oct 2022 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session.
Olaplex Holdings, Inc. (NASDAQ: OLPX) shares
Repligen (RGEN) is a Top-Ranked Growth Stock: Should You Buy?
01:45pm, Monday, 17'th Oct 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Repligen (RGEN) is a Top-Ranked Growth Stock: Should You Buy?
11:17am, Monday, 17'th Oct 2022
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Repligen to Report Third Quarter 2022 Financial Results
11:30am, Wednesday, 12'th Oct 2022 GlobeNewswire Inc.
Webcast and Conference Call to Be Held Tuesday, November 1, 2022 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Tuesday, November 1, 2022 at 8:30 a.m. EDT
Repligen to Report Third Quarter 2022 Financial Results
07:30am, Wednesday, 12'th Oct 2022
Webcast and Conference Call to Be Held Tuesday, November 1, 2022 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Tuesday, November 1, 2022 at 8:30 a.m. EDT
4 under-the-radar stock picks from a five-star fund manager who sees rewards that are worth the risks
01:26pm, Friday, 07'th Oct 2022 MarketWatch
Jonathan Good, manager of the Baird Small/Mid Cap Growth Fund, explains his index-beating strategy in an interview.
4 under-the-radar stock picks from a five-star fund manager who sees rewards that are worth the risks
03:04pm, Thursday, 06'th Oct 2022
It can be tempting to chase performance during any given year, but unfortunately it's a tried-and-true way to lower your investment returns in the long run.
